✦ LIBER ✦

A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: A Gynecologic Oncology Group study

✍ Scribed by Allan J. Jacobs; John A. Blessing; Alan Munoz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of Didemnin B (NSC 3253

✍ Howard Hochster; Ruth Oratz; David S. Ettinger; Ernest Borden 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 56 KB

A Phase II Trial of Anastrozole in Advan

✍ Peter G. Rose; Virginia L. Brunetto; Linda VanLe; Jeffrey Bell; Joan L. Walker; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 45 KB

A Phase II Trial of Topotecan in Patient

✍ David Scott Miller; John A. Blessing; Samuel S. Lentz; Steven E. Waggoner 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Phase II trial of danazol in advanced, r

✍ Allan Covens; Virginia L Brunetto; Maurie Markman; James W Orr Jr.; Samuel S Len 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Phase II Trial of CI-958 in Recurrent Pl

✍ Mark A. Hoffman; John A. Blessing; Mark Morgan 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 34 KB

A Phase II Trial of CI-958 in Recurrent

✍ Mark A. Hoffman; John A. Blessing; Evelyn R. Nuñez 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 34 KB